Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lupus

Showing results (1041-1050 of 5,623) with videos related to

Pageof 563
Sort By:
Lupus|July 17, 2023
BAFFR expression in circulating T follicular helper (CD4<sup>+</sup>CXCR5<sup>+</sup>PD-1<sup>+</sup>) and T peripheral helper (CD4<sup>+</sup>CXCR5<sup>-</sup>PD-1<sup>+</sup>) cells in systemic lupus erythematosusNefertari Sagrero-Fabela, Pablo C Ortíz-Lazareno, Diana C Salazar-Camarena, et al.
Lupus|July 24, 2023
Overlap syndrome of anti-aquaporin-4 positive neuromyelitis optica spectrum disorder and systemic lupus erythematosus: A systematic review of individual patient dataChirag Rajkumar Kopp, Chandra Bhushan Prasad, Shankar Naidu, et al.
Lupus|July 6, 2023
Real-world use and outcomes of belimumab in childhood-onset lupus: A single-center retrospective studyJordan E Roberts, Cordelia Burn, Rebecca E Sadun, et al.
Lupus|January 26, 2019
Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohortG S Alarcón, M F Ugarte-Gil, G Pons-Estel, et al.
Lupus|December 4, 2018
Sexual dimorphism in SLE: above and beyond sex hormonesE A A Christou, A Banos, D Kosmara, et al.
Lupus|December 5, 2018
Bone turnover markers in relation to vitamin D status and disease activity in adults with systemic lupus erythematosusA Sarkissian, V Sivaraman, S Bout-Tabaku, et al.
Lupus|March 21, 2020
Successful treatment of refractory lupus erythematosus profundus with the interleukin-6 antagonist tocilizumab: a case reportGehan Elolemy, Abdulrahman Al Rashidi, Ahmed Dehrab, et al.
Lupus|September 14, 2020
Cell-free DNA profiling in patients with lupus nephritisAnna Truszewska, Agnieszka Wirkowska, Kamila Gala, et al.
Lupus|December 4, 2019
Recovery of renal function in patients with lupus nephritis and reduced renal function: the beneficial effect of hydroxychloroquineJ S Lee, J S Oh, Y-G Kim, et al.
Lupus|December 5, 2019
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)B Hernández Cruz, F Alonso, J Calvo Alén, et al.
Pageof 563

Showing results (1041-1050 of 5,623) with videos related to

Sort By:
Pageof 563
Lupus|July 17, 2023
BAFFR expression in circulating T follicular helper (CD4<sup>+</sup>CXCR5<sup>+</sup>PD-1<sup>+</sup>) and T peripheral helper (CD4<sup>+</sup>CXCR5<sup>-</sup>PD-1<sup>+</sup>) cells in systemic lupus erythematosusNefertari Sagrero-Fabela, Pablo C Ortíz-Lazareno, Diana C Salazar-Camarena, et al.
Lupus|July 24, 2023
Overlap syndrome of anti-aquaporin-4 positive neuromyelitis optica spectrum disorder and systemic lupus erythematosus: A systematic review of individual patient dataChirag Rajkumar Kopp, Chandra Bhushan Prasad, Shankar Naidu, et al.
Lupus|July 6, 2023
Real-world use and outcomes of belimumab in childhood-onset lupus: A single-center retrospective studyJordan E Roberts, Cordelia Burn, Rebecca E Sadun, et al.
Lupus|January 26, 2019
Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohortG S Alarcón, M F Ugarte-Gil, G Pons-Estel, et al.
Lupus|December 4, 2018
Sexual dimorphism in SLE: above and beyond sex hormonesE A A Christou, A Banos, D Kosmara, et al.
Lupus|December 5, 2018
Bone turnover markers in relation to vitamin D status and disease activity in adults with systemic lupus erythematosusA Sarkissian, V Sivaraman, S Bout-Tabaku, et al.
Lupus|March 21, 2020
Successful treatment of refractory lupus erythematosus profundus with the interleukin-6 antagonist tocilizumab: a case reportGehan Elolemy, Abdulrahman Al Rashidi, Ahmed Dehrab, et al.
Lupus|September 14, 2020
Cell-free DNA profiling in patients with lupus nephritisAnna Truszewska, Agnieszka Wirkowska, Kamila Gala, et al.
Lupus|December 4, 2019
Recovery of renal function in patients with lupus nephritis and reduced renal function: the beneficial effect of hydroxychloroquineJ S Lee, J S Oh, Y-G Kim, et al.
Lupus|December 5, 2019
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)B Hernández Cruz, F Alonso, J Calvo Alén, et al.
Pageof 563